Key facts
| Price (PPV) | 931 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | acide mycophénolique - mycophénolate mofétil |
| Class | Immunosuppressants |
| ATC code | L04AA06 |
| Manufacturer | ROCHE S.A |
| Presentation | Boîte de 100 |
| Nature | Médicament |
| Hospital price | 650 MAD |
| Data collected on | 9/8/2026 |
Indications
CellCept est indiqué en association avec des corticoïdes et la ciclosporine pour la prévention des réactions de rejet aiguës chez les patients bénéficiant d'une allogreffe de rein, de cœur ou de foie. Source : Compendium.ch - Date : 20 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Cellcept 250 mg
Cellcept 250 mg belongs to the immunosuppressants therapeutic class. In Morocco, this drug is marketed by ROCHE S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Cellcept 250 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Cellcept 250 mg
Answers to common questions from Moroccan patients about this drug.